Attached files

file filename
EX-99.4 - EX-99.4 - PACIFIC BIOSCIENCES OF CALIFORNIA, INC.pacb-20151022ex9942023b2.htm
EX-99.3 - EX-99.3 - PACIFIC BIOSCIENCES OF CALIFORNIA, INC.pacb-20151022ex99322d4ad.htm
8-K - 8-K - PACIFIC BIOSCIENCES OF CALIFORNIA, INC.pacb-20151022x8k.htm
EX-99.2 - EX-99.2 - PACIFIC BIOSCIENCES OF CALIFORNIA, INC.pacb-20151022xex992.htm

Exhibit 99.1

PACIFIC BIOSCIENCES OF CALIFORNIA, INC.

Condensed Consolidated Balance Sheets

(Unaudited)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

September 30,

 

December 31,

(in thousands except par value amounts)

 

2015

 

2014

Assets

 

 

 

 

 

 

Current assets

 

 

 

 

 

 

Cash and cash equivalents

 

$

27,208 

 

$

36,449 

Investments

 

 

31,701 

 

 

64,899 

Accounts receivable

 

 

4,164 

 

 

3,406 

Inventory

 

 

11,621 

 

 

11,335 

Prepaid expenses and other current assets

 

 

11,513 

 

 

1,671 

Total current assets

 

 

86,207 

 

 

117,760 

Property and equipment, net

 

 

7,855 

 

 

6,601 

Other long-term assets

 

 

5,715 

 

 

162 

Total assets

 

$

99,777 

 

$

124,523 

 

 

 

 

 

 

 

Liabilities and Stockholders' Equity

 

 

 

 

 

 

Current liabilities

 

 

 

 

 

 

Accounts payable

 

$

6,097 

 

$

5,608 

Accrued expenses

 

 

11,342 

 

 

11,441 

Deferred service revenue, current

 

 

6,303 

 

 

6,121 

Deferred contractual revenue, current

 

 

14,385 

 

 

6,785 

Other liabilities, current

 

 

627 

 

 

1,534 

Total current liabilities

 

 

38,754 

 

 

31,489 

Deferred service revenue, non-current

 

 

1,250 

 

 

1,129 

Deferred contractual revenue, non-current

 

 

1,347 

 

 

19,735 

Other liabilities, non-current

 

 

1,323 

 

 

2,153 

Notes payable

 

 

14,808 

 

 

14,124 

Financing derivative

 

 

925 

 

 

944 

Total liabilities

 

 

58,407 

 

 

69,574 

 

 

 

 

 

 

 

Commitments and contingencies

 

 

 

 

 

 

 

 

 

 

 

 

 

Stockholders’ equity

 

 

 

 

 

 

Preferred Stock, $0.001 par value:

 

 

 

 

 

 

Authorized 50,000 shares; No shares issued or outstanding

 

 

 —

 

 

 —

Common Stock, $0.001 par value:

 

 

 

 

 

 

Authorized 1,000,000 shares; Issued and outstanding 75,705 shares at September 30, 2015 and 73,927 shares at December 31, 2014

 

 

76 

 

 

74 

Additional paid-in capital

 

 

753,048 

 

 

736,339 

Accumulated other comprehensive income

 

 

 

 

Accumulated deficit

 

 

(711,760)

 

 

(681,473)

Total stockholders’ equity

 

 

41,370 

 

 

54,949 

Total liabilities and stockholders’ equity

 

$

99,777 

 

$

124,523